Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses

Journal of General Virology

Volumn 94, Issue PART3, 2013, Pages 583-592

  Hillaire, Marine L B ^a   Vogelzang van Trierum, Stella E ^a   Kreijtz, Joost H C M ^a   de Mutsert, Gerrie ^a   Fouchier, Ron A M ^a   Osterhaus, Albert D M E ^a,b   Rimmelzwaan, Guus F ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Viroclinics Biosciences BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

2009 H1N1 INFLUENZA; AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLUENZA A (H3N2); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; NONHUMAN; PANDEMIC INFLUENZA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; EPITOPES; GENETIC VARIATION; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS;

EID: 84874094119     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.048652-0     Document Type: Article

References (60)

1. Bodewes, R., de Mutsert, G., van der Klis, F. R., Ventresca, M., Wilks, S., Smith, D. J., Koopmans, M., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2011). Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands. Clin Vaccine Immunol 18, 469-476.
2. Boon, A. C., de Mutsert, G., Graus, Y. M., Fouchier, R. A., Sintnicolaas, K., Osterhaus, A. D. & Rimmelzwaan, G. F. (2002). The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype. J Virol 76, 582-590.
3. Boon, A. C., De Mutsert, G., Fouchier, R. A., Sintnicolaas, K., Osterhaus, A. D. & Rimmelzwaan, G. F. (2004a). Preferential HLA usage in the influenza virus-specific CTL response. J Immunol 172, 4435-4443.
4. + T lymphocytes. J Immunol 172, 2453-2460.
5. Bui, H. H., Sidney, J., Li, W., Fusseder, N. & Sette, A. (2007). Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics 8, 361.
6. CDC (2011a). CDC Confirms Two Human Infections with Novel Influenza Viruses. Centers for Disease Control and Prevention. http://www.cdc.gov/media/haveyouheard/stories/novel_influenza.html
7. CDC (2011b). Limited Human-to-human Transmission of Novel Influenza A (H3N2) Virus-Iowa, November 2011. MMWR Morb Mortal Wkly Rep 60, 1615-1617.
8. CDC (2012a). Evaluation of Rapid Influenza Diagnostic Tests for Influenza A (H3N2)v Virus and Updated Case Count United States, 2012. Centers for Disease Control and Prevention. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6132a4.htm
9. CDC (2012b). First H3N2 variant virus infection reported for 2012. Centers for Disease Control and Prevention. http://www.cdc.gov/flu/spotlights/h3n2v-variant-utah.htm
10. CDC (2012c). Influenza A (H3N2) variant virus. Centers for Disease Control and Prevention. http://www.cdc.gov/flu/swineflu/h3n2v-outbreak.htm
11. CDC (2012d). Notes from the field: outbreak of influenza A (H3N2) virus among persons and swine at a county fair Indiana, July 2012. MMWR Morb Mortal Wkly Rep 61, 561.
12. Claas, E. C., Kawaoka, Y., de Jong, J. C., Masurel, N. & Webster, R. G. (1994). Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology 204, 453-457.
13. Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P.-Y., Bandaranayake, D., Breiman, R. F., Brooks, W. A. & other authors (2012). Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis 12, 687-695.
14. de Jong, J. C., de Ronde-Verloop, J. M., Bangma, P. J., van Kregten, E., Kerckhaert, J., Paccaud, M. F., Wicki, F. & Wunderli, W. (1986). Isolation of swine-influenza-like A(H1N1) viruses from man in Europe, 1986. Lancet 328, 1329-1330.
15. de Jong, J. C., Claas, E. C., Osterhaus, A. D., Webster, R. G. & Lim, W. L. (1997). A pandemic warning? Nature 389, 554
16. Ducatez, M. F., Hause, B., Stigger-Rosser, E., Darnell, D., Corzo, C., Juleen, K., Simonson, R., Brockwell-Staats, C., Rubrum, A. & other authors (2011). Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis 17, 1624-1629.
17. Fan, X., Zhu, H., Zhou, B., Smith, D. K., Chen, X., Lam, T. T., Poon, L. L., Peiris, M. & Guan, Y. (2012). Emergence and dissemination of a swine H3N2 reassortant influenza virus with 2009 pandemic H1N1 genes in pigs in China. J Virol 86, 2375-2378.
18. Fouchier, R. A., Schneeberger, P. M., Rozendaal, F. W., Broekman, J. M., Kemink, S. A., Munster, V., Kuiken, T., Rimmelzwaan, G. F., Schutten, M. & other authors (2004). Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A 101, 1356-1361.
19. Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E. & other authors (2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197-201.
20. Gaydos, J. C., Hodder, R. A., Top, F. H., Jr, Soden, V. J., Allen, R. G., Bartley, J. D., Zabkar, J. H., Nowosiwsky, T. & Russell, P. K. (1977). Swine influenza A at Fort Dix, New Jersey (January-February 1976). I. Case finding and clinical study of cases. J Infect Dis 136 (Suppl.), S356-S362.
21. Girard, M. P., Tam, J. S., Assossou, O. M. & Kieny, M. P. (2010). The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 28, 4895-4902.
22. + T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc Natl Acad Sci U S A 107, 12599-12604.
23. Grebe, K. M., Yewdell, J. W. & Bennink, J. R. (2008). Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect 10, 1024-1029.
24. Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R. & other authors (2009). Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361, 1945-1952.
25. Herfst, S., Schrauwen, E. J., Linster, M., Chutinimitkul, S., de Wit, E., Munster, V. J., Sorrell, E. M., Bestebroer, T. M., Burke, D. F. & other authors (2012). Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336, 1534-1541.
26. Hillaire, M. L., Osterhaus, A. D. & Rimmelzwaan, G. F. (2011a). Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines. J Biomed Biotechnol 2011, 939860.
27. Hillaire, M. L., van Trierum, S. E., Kreijtz, J. H., Bodewes, R., Geelhoed-Mieras, M. M., Nieuwkoop, N. J., Fouchier, R. A., Kuiken, T., Osterhaus, A. D. & Rimmelzwaan, G. F. (2011b). Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells. J Gen Virol 92, 2339-2349.
28. Imai, M., Watanabe, T., Hatta, M., Das, S. C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H. & other authors (2012). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486, 420-428.
29. Ito, T., Couceiro, J. N., Kelm, S., Baum, L. G., Krauss, S., Castrucci, M. R., Donatelli, I., Kida, H., Paulson, J. C. & other authors (1998). Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72, 7367-7373.
30. + T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol 162, 7578-7583.
31. Kreijtz, J. H., de Mutsert, G., van Baalen, C. A., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2008). Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82, 5161-5166
32. Lee, L. Y., Ha, L. A., Simmons, C., de Jong, M. D., Chau, N. V., Schumacher, R., Peng, Y. C., McMichael, A. J., Farrar, J. J. & other authors (2008). Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118, 3478-3490.
33. Lin, Y. P., Shaw, M., Gregory, V., Cameron, K., Lim, W., Klimov, A., Subbarao, K., Guan, Y., Krauss, S. & other authors (2000). Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A97,9654-9658.
34. Lukacher, A. E., Braciale, V. L. & Braciale, T. J. (1984). In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 160, 814-826.
35. Matrosovich, M. N., Gambaryan, A. S., Teneberg, S., Piskarev, V. E., Yamnikova, S. S., Lvov, D. K., Robertson, J. S. & Karlsson, K. A. (1997). Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 233, 224-234
36. McMichael, A. J., Gotch, F. M., Noble, G. R. & Beare, P. A. (1983). Cytotoxic T-cell immunity to influenza. N Engl J Med 309, 13-17
37. Neumann, G., Noda, T. & Kawaoka, Y. (2009). Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931-939.
38. Olsen, C. W., Karasin, A. I., Carman, S., Li, Y., Bastien, N., Ojkic, D., Alves, D., Charbonneau, G., Henning, B. M. & other authors (2006). Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 12, 1132-1135.
39. Patriarca, P. A., Kendal, A. P., Zakowski, P. C., Cox, N. J., Trautman, M. S., Cherry, J. D., Auerbach, D. M., McCusker, J., Belliveau, R. R. & Kappus, K. D. (1984). Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immune compromised child. Am J Epidemiol 119, 152-158.
40. Pearce, M. B., Jayaraman, A., Pappas, C., Belser, J. A., Zeng, H., Gustin, K. M., Maines, T. R., Sun, X., Raman, R. & other authors (2012). Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A 109, 3944-3949
41. Rimmelzwaan, G. F., Baars, M., Claas, E. C. & Osterhaus, A. D. (1998). Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods 74, 57-66.
42. Rimmelzwaan, G. F., de Jong, J. C., Bestebroer, T. M., van Loon, A. M., Claas, E. C., Fouchier, R. A. & Osterhaus, A. D. (2001). Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in The Netherlands. Virology 282, 301-306
43. Rogers, G. N. & D'Souza, B. L. (1989). Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173, 317-322
44. Seo, S. H. & Webster, R. G. (2001). Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 75, 2516-2525
45. Skowronski, D. M., De Serres, G., Janjua, N. Z., Gardy, J. L., Gilca, V., Dionne, M., Hamelin, M. E., Rhéaume, C. & Boivin, G. (2012a). Cross reactive antibody to swine influenza A(H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro Surveill 17, 20066.
46. Skowronski, D. M., Janjua, N. Z., De Serres, G., Purych, D., Gilca, V., Scheifele, D. W., Dionne, M., Sabaiduc, S., Gardy, J. L. & other authors (2012b). Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v). J Infect Dis 206, 1852-1861.
47. Suzuki, Y. (2005). Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses. Biol Pharm Bull 28, 399-408
48. Taylor, P. M. & Askonas, B. A. (1986). Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology 58, 417-420.
49. Thompson, C. I., Barclay, W. S., Zambon, M. C. & Pickles, R. J. (2006). Infection of human airway epithelium by human and avian strains of influenza A virus. J Virol 80, 8060-8068.
50. Tu, W., Mao, H., Zheng, J., Liu, Y., Chiu, S. S., Qin, G., Chan, P.-L., Lam, K.-T., Guan, J. & other authors (2010). Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J Virol 84, 6527-6535.
51. Ungchusak, K., Auewarakul, P., Dowell, S. F., Kitphati, R., Auwanit, W., Puthavathana, P., Uiprasertkul, M., Boonnak, K., Pittayawonganon, C. & other authors (2005). Probable person-to person transmission of avian influenza A (H5N1). N Engl J Med 352, 333-340.
52. Voeten, J. T., Bestebroer, T. M., Nieuwkoop, N. J., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2000). Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74, 6800-6807.
53. Wentworth, D. E., Thompson, B. L., Xu, X., Regnery, H. L., Cooley, A. J., McGregor, M. W., Cox, N. J. & Hinshaw, V. S. (1994). An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol 68, 2051-2058.
54. WHO (2009). Pandemic (H1N1) 2009 Update 112. Geneva, Switzerland: World Health Organization. Available at: http://www.who.int/csr/don/2010_08_06/en/index.html.
55. WHO (2010). Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1). Geneva, Switzerland: World Health Organization. http://www.who.int/influenza/human_animal_interface/EN_GIP_20120810CumulativeNumberH5N1cases.pdf.
56. WHO (2011). Standardization of Terminology for the Variant A(H3N2) Virus Recently Infecting Humans. Geneva, Switzerland: World Health Organization. http://www.who.int/influenza/gisrs_laboratory/terminology_ah3n2v/en/.
57. + T cells correlate with disease protection against influenza challenge in humans. Nat Med 18, 274-280.
58. Yang, Z. Y., Huang, Y., Ganesh, L., Leung, K., Kong, W. P., Schwartz, O., Subbarao, K. & Nabel, G. J. (2004). pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 78, 5642-5650.
59. Yang, Y., Halloran, M. E., Sugimoto, J. D. & Longini, I. M., Jr (2007). Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis 13, 1348-1353.
60. Yap, K. L., Ada, G. L. & McKenzie, I. F. (1978). Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273, 238-239.